Shares in Dr Martens, the UK-based shoemaker, soared 8.5% in early morning trading on Tuesday following the company's latest annual results. The results showed a significant increase in profit growth, driven by sharp cost-cutting measures across the business. As a result, shares in the company are now up 22.1% over the last year.
Despite the positive news, Dr Martens shares remain down 7.4% over the past year. However, the company's latest results suggest that its turnaround strategy is beginning to pay off. The company reported a profit of £22.1m in the year to March 31, up from a loss of £6.6m in the previous year.
Dr Martens' cost-cutting measures included reducing its workforce and renegotiating contracts with suppliers. The company also invested in its e-commerce platform, which has helped to drive sales growth. The company's sales increased by 12.1% in the year to March 31, driven by strong demand for its iconic AirWair boots and shoes.
The news is likely to be welcomed by investors, who have been watching the company's turnaround efforts closely. The company's shares are listed on the London Stock Exchange, and the FTSE 100 index is likely to be affected by the news. The FTSE 100 has already risen 0.5% in early trading, driven by the positive news from Dr Martens.
For UK savers and investors, the news is likely to be encouraging, as it suggests that the company's turnaround strategy is working. However, it is always important to seek advice from a qualified financial adviser before making any investment decisions. Dr Martens' shares are currently trading at 69.8p, and the company's revenue has increased by 12.1% in the year to March 31.